Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹38,385.2 Cr 7.9% 29.6% 57.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,725.0 Cr -3.2% 10.5% 9.3% Stock Analytics
DIVIS LABORATORIES ₹182,775.0 Cr 0.8% 9.5% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,764.0 Cr 2% 9.9% 35.4% Stock Analytics
CIPLA ₹113,007.0 Cr -1.9% 13.3% -6% Stock Analytics
DR REDDYS LABORATORIES ₹109,098.0 Cr -1.8% 7.4% 8.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

7.9%

29.6%

57.5%

SENSEX

0.2%

-4.9%

-8.4%


You may also like the below Video Courses